{"title": "Did Canada agree to psychiatric counselling for the treatment of depression and anxiety?", "subtitle": "Research suggests that fungus hallucinations may address some health issues.", "author": "Madison Dapcevich", "date": "18 November 2020", "vclaim_id": "vclaim-sno-canada-psychedelic-depression", "vclaim": "In November 2020, the Canadian government approved the use of selysippine therapy, which uses hallucinogenic chemical compound found in hallucinations mushrooms, to alleviate anxiety and depression associated with final diagnosis."}